Yiliang Li - Publications & Citations

Yiliang Li

shandong university

0H指数

1论文数

0被引数

收录论文 8

发表时间

Group-Based Joint Strategy Fictitious Play With Inertia for Potential Games 基于群组的惯性假想博弈联合策略博弈

IEEE Transactions on Automatic Control

IF7

2026-03-04

PREAI

Yanfei Wang; Yiliang Li; Jun-e Feng

Elucidation of novel diagnostic biomarkers and therapeutic targets in colorectal carcinoma: an integrative approach leveraging multi-omics, computational biology, and single-cell sequencing technologies 阐明结直肠癌中新型诊断生物标志物和治疗靶点：一种整合多组学、计算生物学和单细胞测序技术的综合方法

Mammalian Genome

IF2.7

2025-06-25

PREAI

Tingyang Li; Yuhua Tian; Yinchuan Wang; Jianle Yang; Ziyu Chen; Yiliang Li

Metagenomic insight into the pathogenic-related characteristics and resistome profiles within microbiome residing on the Angkor sandstone monuments in Cambodia

SCIENCE OF THE TOTAL ENVIRONMENT

IF8

2024-03-01

PREAI

Ding, Xinghua; Lan, Wensheng; Li, Jing; Deng, Maocheng; Li, Yiliang; Katayama, Yoko; Gu, Ji-Dong

SUMO-specific protease 1 inhibitors-A literature and patent overview

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2023-01-31

PREAI

Li, Hang; Chen, Leyuan; Li, Yiliang; Hou, Wenbin

Targeted inhibition of acidic nucleoplasmic DNA-binding protein 1 enhances radiosensitivity of non-small cell lung cancer

CANCER LETTERS

IF10.1

2022-04-01

PREAI

Gou, Wenfeng; Yu, Xiaojun; Wu, Shaohua; Wu, Hongying; Chang, Huajie; Chen, Leyuan; Wei, Huiqiang; Bi, Changfen; Ning, Hongxin; Wu, Yingliang; Hou, Wenbin; Zuo, Daiying; Li, Yiliang

Set controllability of Boolean control networks with impulsive effects

NEUROCOMPUTING

IF6.5

2020-12-01

PREAI

Li, Yiliang; Li, Jinjin; Feng, Jun-e

Facile synthesis of hydrophilic magnetic graphene nanocomposites via dopamine self-polymerization and Michael addition for selective enrichment of N-linked glycopeptides

SCIENTIFIC REPORTS

IF3.9

2020-01-09

OAAI

Bi, Changfen; Yuan, Ye; Tu, Yuran; Wu, Jiahui; Liang, Yulu; Li, Yiliang; He, Xiwen; Chen, Langxing; Zhang, Yukui

Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors

EXPERT OPINION ON INVESTIGATIONAL DRUGS

IF4.1

2019-08-29

111

PREAI

Chen, Leyuan; Duan, Yuqing; Wei, Huiqiang; Ning, Hongxin; Bi, Changfen; Zhao, Ying; Qin, Yong; Li, Yiliang

研究方向